Surgical Oncology & Robotic Cancer Surgery
Dr. Rajesh Kumar Jain
BLK-Max Super Speciality Hospital, Delhi
- BLK-Max Super Speciality Hospital, Delhi
- Principal Director - Surgical Oncology
- BLK-Max Super Speciality Hospital, Delhi
- Appointment: +91-11-30403040
- Surgical Oncology
- Principal Director - Surgical Oncology
Dr. Rajesh Kumar Jain
Surgical Oncology & Robotic Cancer Surgery
Principal Director - Surgical Oncology
- Dr. Rajesh Kumar Jain is a surgical oncologist with 26+ years of experience at BLK-Max Super Speciality Hospital, New Delhi. His areas of expertise include cancers of the head and neck, breast, thoracic region, gastrointestinal tract, gynaecological region and urinary tract.
About Dr. Rajesh Kumar Jain
Dr. Rajesh Kumar Jain is Principal Director - Surgical Oncology at BLK-Max Super Speciality Hospital. His official profile highlights his work in surgical oncology, development of surgical oncology services, research, and mentoring junior doctors.
Clinical Department & Special Interests
- Robotic Cancer Surgeries
- Head & Neck Cancer Surgeries
- Breast Cancer Surgeries
- Gynaecological Cancer Surgeries
- Thoracic & Gastrointestinal Cancer Surgeries
- Uro-Cancer Surgeries
Professional Experience
- Principal Director - Surgical Oncology, BLK-Max Super Speciality Hospital, New Delhi
- Director & Head - Surgical Oncology, Action Cancer Hospital, New Delhi
- Consultant & Head - Surgical Oncology, BLK Super Speciality Hospital, New Delhi
- Consultant - Surgical Oncology, Rajiv Gandhi Cancer Institute, New Delhi
- Registrar - Surgical Oncology, Indraprastha Apollo Hospital, New Delhi
Education & Training
- MBBS
- MS (General Surgery)
- DNB (Surgical Oncology)
Professional Memberships
- Indian Society of Oncology
Awards & Recognition
No awards are listed in the official BLK-Max profile reviewed for this page.
Hospital Profile
Dr. Rajesh Kumar Jain is associated with BLK-Max Super Speciality Hospital, Delhi, as Principal Director - Surgical Oncology. His official profile highlights surgical oncology services for multiple cancer types and an interest in robotic cancer surgery.



